Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02726763 · ClinicalTrials.gov registry record · NA

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

A NA study of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02726763 is a NA study of Breast Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 18 participants, below the 2,759-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02726763, a NA study of Breast Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.

Conditions Studied

Breast Cancer Survivors

Interventions

  • BEHAVIORAL Questionnaires
  • DEVICE Transcranial Direct Current Stimulation (tDCS)

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2016-03-30
Est. Completion 2026-03
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02726763

The ClinicalTrials.gov registry entry for NCT02726763 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,759-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (99% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.

NCT02726763 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02726763 about?

NCT02726763 is a clinical study titled "Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training". In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.

What is the current status of trial NCT02726763?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2016-03-30. Estimated completion is 2026-03.

What conditions does trial NCT02726763 study?

This clinical trial studies the following conditions: Breast Cancer Survivors.

What interventions are being tested in trial NCT02726763?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Transcranial Direct Current Stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT02726763?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02726763 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer Survivors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer Survivors

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.